Epizyme releases additional data from Phase 1 study of tazemetostat in non-Hodgkin’s lymphoma
22 June 2015 | By Victoria White
Epizyme has reported results from the ongoing Phase 1 trial of tazemetostat in patients with advanced B-cell non-Hodgkin's lymphoma and solid tumours...